Interstitial Lung Disease (ILD) Clinical Trials

Interventional Studies

A randomized, clinical study to determine whether BI 1015550 improves lung function in people with Idiopathic Pulmonary Fibrosis (IPF)
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Claire McGroder, MD
Active, Not Recruiting
Start Date: September 2022
End Date: November 2024
Clinical Trials.gov: NCT05321069

A randomized, clinical study to evaluate whether BI 1015550 improves lung function in people with progressive fibrosing interstitial lung diseases
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: David Zhang, MD
Active, Not Recruiting
Start Date: October 2022
End Date: March 2025
Clinical Trials.gov: NCT05321082

A randomized, clinical trial to evaluate whether inhaled pirfenidone solution improves lung function in people with progressive pulmonary fibrosis (PPF)
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Claire McGroder, MD
Actively Recruiting
Expected Start Date: June 2024
End Date: August 2025
Clinical Trials.gov: NCT06329401

A randomized, clinical trial to determine whether PLN-74809 (Bexotegrast) stabilizes fibrosis in people with idiopathic pulmonary fibrosis (IPF)
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Christina Eckhardt, MD
Actively Recruiting
Expected Start Date: July 2024
End Date: December 2025
Clinical Trials.gov: NCT06097260

A randomized, clinical study investigating a wellness-based intervention for patients with newly diagnosed Interstitial Lung Disease
Contact: Christopher Depender; cd2686@cumc.columbia.edu(link sends e-mail)
Principal Investigator: Claire McGroder, MD
Active, Not Recruiting
Start Date: September 2020
End Date: September 2024

A prospective cohort study designed to study the long-term pulmonary consequences of severe COVID-19.
Contact: William Quigley; wrq2103@cumc.columbia.edu
Principal Investigator: Christine K. Garcia MD, PhD
Active
Start Date: 8/1/2020
End Date: 12/31/2024

A prospective study in collaboration with Dr. Erica Farrand at the University of San Francisco (funded by the Nina Ireland Program for Lung Health). This study plans to recruit recently diagnosed subjects with pulmonary fibrosis to compare standard-of-care telomere length blood tests.
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Christine K. Garcia MD, PhD
Active, Not Yet Recruiting
Expected Start Date: 06/15/2024
End Date: 12/31/2024

A collaborative, University-wide, biobank for collection of biological samples (blood, lung tissue) along with health data from patients that is collected during their medical care. The goal of the biobank is to provide researchers with a resource to help them better understand, treat, and prevent disease.
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Christine Kim Garcia, MD, PhD, on behalf of the multi-investigator study group
Not yet recruiting
Start Date: Summer 2024
End Date: Ongoing
CUB: For Participants | Vagelos College of Physicians and Surgeons (columbia.edu)

A collaborative approach to identify genetic causes of lung diseases and to create a repository to better understand, prevent, and treat these conditions. Members of study group include specialists from the Division of Pulmonary, Allergy, and Critical Care Medicine at Columbia University Irving Medical Center.
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Christine Kim Garcia, MD, PhD, on behalf of the multi-investigator study group
Active
Start Date: October 2019
End Date: Ongoing
View on RecruitMe

A prospective cohort study designed to identify genetic causes of heart and lung diseases and to develop a repository to better understand, prevent and treat these conditions. Individuals may be asked to donate a sample of blood, a skin sample, or cells/tissue removed as part of medical care.
Contact: Christopher Depender; cd2686@cumc.columbia.edu
Principal Investigator: Christine Kim Garcia, MD, PhD
Active
Start Date: December 2018
End Date: Ongoing
View on RecruitMe